Wockhardt Ltd. announced that the drugmaker has received approval from the U.S. health regulator, USFDA, for the generic version of Gleevec used for the treatment...
According to the latest U.S. Food and Drug Administration’s (USFDA) Enforcement Report, Indian pharma major such as Lupin, Sun Pharma and Glenmark has decided to...
Zydus Cadila has announced that the US health regulator has given final approval to market generic Abacavir and Lamivudine tablets, which are primarily used for...
Morepen Laboratories has received approval for its Baddi facility at Himachal Pradesh, from USFDA. The company’s Baddi facility has received approval for the manufacture of bulk drug Atorvastatin...
Zydus Cadila has received final approvals from the US health regulator, to market four generic products in America. The approvals received are for Olanzapine tablets in strengths...
Glenmark Pharma has received final approval for Colesevelam Hydrochloride, from USFDA. Colesevelam Hydrochloride is a generic version of Welchol 1 of Daiichi Sankyo Inc and the...
Cadila Healthcare has received final approval for Zolmitriptan tablets USP, from the USFDA. The company has received final approval to market Zolmitriptan Tablets, 2.5 mg and 5 mg,...
Aurobindo Pharma has received final approval to manufacture and market Azithromycin tablets, from the USFDA. The tablets are used for the treatment of patients with mild...
Shilpa Medicare has received establishment inspection report (EIR), from United States Food and Drug Administration (USFDA). The company has received of EIR for both API manufacturing...